Showing results (361-370 of 599) with videos related to

Sort By:
Pageof 60
Arthritis Research & Therapy|January 6, 2022
Acazicolcept (ALPN-101), a dual ICOS/CD28 antagonist, demonstrates efficacy in systemic sclerosis preclinical mouse modelsCindy Orvain, Anne Cauvet, Alexis Prudent, et al.
The Journal of Rheumatology|April 17, 2017
Takayasu Arteritis and Spondyloarthritis: Coincidence or Association? A Study of 14 CasesElodie Rivière, Laurent Arnaud, Mikael Ebbo, et al.
Clinical Immunology (Orlando, Fla.)|June 9, 2004
IgG reactivity with a 100-kDa tissue and endothelial cell antigen identified as topoisomerase 1 distinguishes between limited and diffuse systemic sclerosis patientsPaloma García de la Peña-Lefebvre, Youri Chanseaud, Mathieu C Tamby, et al.
The Journal of Rheumatology|September 3, 2010
Prevalence of pulmonary hypertension in systemic sclerosis in European Caucasians and metaanalysis of 5 studiesJérôme Avouac, Paolo Airò, Christophe Meune, et al.
Rheumatology (Oxford, England)|June 3, 2025
Lung function and skin fibrosis changes as predictors of survival in SSc-associated interstitial lung disease: a EUSTAR studyVincent Sobanski, Jeska de Vries-Bouwstra, Anna-Maria Hoffmann-Vold, et al.
The Journal of Rheumatology|June 3, 2009
Serologic profile and mortality rates of scleroderma renal crisis in ItalyVeronica Codullo, Ilaria Cavazzana, Claudia Bonino, et al.
The Journal of Rheumatology|February 19, 2008
Polymorphic markers of the fibrillin-1 gene and systemic sclerosis in European Caucasian patientsJulien Wipff, Matthieu Giraud, Jean Sibilia, et al.
Rheumatology (Oxford, England)|December 3, 2019
Incidence and risk factors for gangrene in patients with systemic sclerosis from the EUSTAR cohortCarina Mihai, Oliver Distler, Ana Maria Gheorghiu, et al.
Frontiers in Immunology|September 5, 2018
The Nrf2-Antioxidant Response Element Signaling Pathway Controls Fibrosis and Autoimmunity in SclerodermaNiloufar Kavian, Souad Mehlal, Mohamed Jeljeli, et al.
Clinical and Experimental Rheumatology|August 5, 2022
New onset and flare of rheumatic diseases following COVID-19 vaccination are mild and respond well to treatment: 9-month follow-up data from a single centre cohortMichela Gasparotto, Sara Bindoli, Roberto Padoan, et al.
Pageof 60